Oncobiologics, Inc. (ONS) has 10 open-market insider trades by 7 insiders since 2016. The most active filer is Pankaj Mohan, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Pankaj Mohan | CEOPres | — | 2 | $483K | 2018-01-04 |
| Scott A. Gangloff | VP | — | 1 | $280K | 2016-12-21 |
| Stephen J. McAndrew | VP | — | 1 | $160K | 2017-12-22 |
| Lawrence A. Kenyon | CEOPresCFOTreas & Secy | — | 2 | $38K | 2018-09-18 |
| Elizabeth A. Yamashita | VP | — | 2 | $27K | 2017-12-22 |
| Kenneth Bahrt | Chief Medical Officer | — | 1 | $7K | 2018-06-25 |
| Donald J. Griffith | Dir | — | 1 | $4 | 2016-11-23 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Lawrence A. Kenyon | CEO & President +2 | Sell | $9K | 2018-09-18 |
| Kenneth Bahrt | Chief Medical Officer | Sell | $7K | 2018-06-25 |
| Pankaj Mohan | CEO & President | Sell | $268K | 2018-01-03 |
| Lawrence A. Kenyon | Secretary | Sell | $30K | 2017-12-22 |
| Elizabeth A. Yamashita | VP & Regulatory Affairs | Sell | $18K | 2017-12-22 |
| Stephen J. McAndrew | SVP Bus. Strat. & Dev. | Sell | $18K |
Companies that share insiders with ONS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2017-12-22 |
| Elizabeth A. Yamashita | VP | Sell | $9K | 2017-12-18 |
| Pankaj Mohan | CEO & President | Sell | $215K | 2017-12-18 |
| Donald J. Griffith | Director | Sell | $4 | 2016-11-23 |
| Stephen J. McAndrew | VP | Sell | $160K | 2016-11-11 |
| Scott A. Gangloff | VP | Sell | $280K | 2016-11-11 |